Free Trial

Ovintiv (NYSE:OVV) Stock Price Down 7.2% - Time to Sell?

Ovintiv logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • Shares of Ovintiv fell 7.2% intraday to $56.36 from $60.73, with only ~1.16M shares trading — roughly 77% below the average session volume — suggesting the drop occurred on lighter-than-normal volume.
  • The stock has a consensus rating of Moderate Buy with an average price target of $59.95, and several firms recently raised targets (e.g., Scotiabank $65, Citigroup $62, Goldman Sachs $62).
  • Fundamentals include a Q4 EPS beat ($1.39 vs. $0.98 expected), a PE of 11.63, $15.93B market cap, and a $0.30 quarterly dividend (2.1% yield) with a ~25% payout ratio.
  • Five stocks to consider instead of Ovintiv.

Shares of Ovintiv Inc. (NYSE:OVV - Get Free Report) fell 7.2% during mid-day trading on Wednesday . The company traded as low as $55.41 and last traded at $56.3590. 1,157,174 shares changed hands during trading, a decline of 77% from the average session volume of 4,951,288 shares. The stock had previously closed at $60.73.

Analyst Upgrades and Downgrades

OVV has been the subject of several analyst reports. Scotiabank upped their target price on Ovintiv from $58.00 to $65.00 and gave the stock a "sector outperform" rating in a research report on Thursday, March 19th. Citigroup reaffirmed a "neutral" rating and issued a $62.00 target price (up from $52.00) on shares of Ovintiv in a research report on Monday, March 30th. Roth Mkm upped their target price on Ovintiv from $42.00 to $50.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 24th. Stephens raised Ovintiv to a "hold" rating in a research report on Tuesday, February 3rd. Finally, The Goldman Sachs Group upped their target price on Ovintiv from $49.00 to $62.00 and gave the stock a "buy" rating in a research report on Wednesday, March 11th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $59.95.

Get Our Latest Report on Ovintiv

Ovintiv Price Performance

The company has a debt-to-equity ratio of 0.39, a current ratio of 0.54 and a quick ratio of 0.54. The business has a fifty day moving average of $52.18 and a 200 day moving average of $43.78. The stock has a market cap of $15.93 billion, a PE ratio of 11.63, a P/E/G ratio of 2.12 and a beta of 0.59.

Ovintiv (NYSE:OVV - Get Free Report) last released its earnings results on Monday, February 23rd. The company reported $1.39 EPS for the quarter, topping analysts' consensus estimates of $0.98 by $0.41. Ovintiv had a return on equity of 12.00% and a net margin of 13.94%.The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.89 billion. During the same quarter last year, the business posted ($0.23) EPS. Sell-side analysts anticipate that Ovintiv Inc. will post 5.59 earnings per share for the current year.

Ovintiv Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Friday, March 13th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Friday, March 13th. Ovintiv's dividend payout ratio is presently 24.79%.

Insider Buying and Selling

In related news, EVP Meghan Nicole Eilers sold 11,582 shares of the stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $54.78, for a total value of $634,461.96. Following the sale, the executive vice president owned 54,092 shares of the company's stock, valued at $2,963,159.76. This trade represents a 17.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Howard John Mayson sold 5,000 shares of Ovintiv stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average price of $52.39, for a total transaction of $261,950.00. Following the completion of the sale, the director owned 45,780 shares in the company, valued at approximately $2,398,414.20. This represents a 9.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.89% of the stock is currently owned by corporate insiders.

Institutional Trading of Ovintiv

Hedge funds have recently bought and sold shares of the company. McIlrath & Eck LLC bought a new stake in Ovintiv in the 3rd quarter valued at about $31,000. Foster Dykema Cabot & Partners LLC acquired a new stake in Ovintiv in the 3rd quarter valued at approximately $36,000. HM Payson & Co. acquired a new stake in Ovintiv in the 3rd quarter valued at approximately $36,000. Quent Capital LLC acquired a new stake in Ovintiv in the 3rd quarter valued at approximately $37,000. Finally, Flagship Harbor Advisors LLC acquired a new stake in Ovintiv in the 4th quarter valued at approximately $38,000. 83.81% of the stock is currently owned by institutional investors.

Ovintiv Company Profile

(Get Free Report)

Ovintiv Inc is a North American energy company focused on the exploration, development and production of oil, natural gas and natural gas liquids. Formerly known as Encana Corporation, the company rebranded as Ovintiv in January 2020 and established its headquarters in Denver, Colorado. Ovintiv's upstream portfolio spans multiple unconventional resource plays, reflecting a strategy centered on high-return projects and disciplined capital allocation.

The company's core business activities include the acquisition and development of acreage in major shale basins across the United States and Canada.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ovintiv Right Now?

Before you consider Ovintiv, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ovintiv wasn't on the list.

While Ovintiv currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines